CAPTRUST Financial Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,439
| Closed | -$354K | – | 2259 |
|
|
2022
Q3 | $354K | Sell |
1,439
-133
| -8% | -$32.7K | ﹤0.01% | 1433 |
|
|
2022
Q2 | $389K | Sell |
1,572
-4,188
| -73% | -$1.04M | ﹤0.01% | 1270 |
|
|
2022
Q1 | $1.91M | Buy |
5,760
+4,686
| +436% | +$1.55M | 0.01% | 608 |
|
|
2021
Q4 | $386K | Sell |
1,074
-119
| -10% | -$42.8K | ﹤0.01% | 1253 |
|
|
2021
Q3 | $388K | Sell |
1,193
-154
| -11% | -$50.1K | ﹤0.01% | 1154 |
|
|
2021
Q2 | $420K | Sell |
1,347
-277
| -17% | -$86.4K | ﹤0.01% | 1067 |
|
|
2021
Q1 | $518K | Buy |
1,624
+638
| +65% | +$204K | 0.01% | 940 |
|
|
2020
Q4 | $320K | Buy |
986
+95
| +11% | +$30.8K | ﹤0.01% | 997 |
|
|
2020
Q3 | $232K | Buy |
891
+249
| +39% | +$64.8K | ﹤0.01% | 974 |
|
|
2020
Q2 | $164K | Buy |
+642
| New | +$164K | ﹤0.01% | 1123 |
|
|
2019
Q4 | – | Sell |
-317
| Closed | -$56K | – | 1943 |
|
|
2019
Q3 | $56K | Buy |
317
+124
| +64% | +$21.9K | ﹤0.01% | 961 |
|
|
2019
Q2 | $50K | Buy |
193
+160
| +485% | +$41.5K | ﹤0.01% | 970 |
|
|
2019
Q1 | $9K | Sell |
33
-70
| -68% | -$19.1K | ﹤0.01% | 1427 |
|
|
2018
Q4 | $33K | Buy |
103
+95
| +1,188% | +$30.4K | ﹤0.01% | 882 |
|
|
2018
Q3 | $4K | Hold |
8
| – | – | ﹤0.01% | 1416 |
|
|
2018
Q2 | $3K | Sell |
8
-77
| -91% | -$28.9K | ﹤0.01% | 1393 |
|
|
2018
Q1 | $24K | Buy |
+85
| New | +$24K | ﹤0.01% | 776 |
|